The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aadi Bioscience Inc | Common | 00032Q104 | 13,108 | 772,416 | SH | SOLE | 772,416 | 0 | 0 | ||
| Aclaris Therapeutics, Inc. | Common | 00461U105 | 15,492 | 898,631 | SH | SOLE | 898,631 | 0 | 0 | ||
| Aligos Therapeutics Inc | Common | 01626L105 | 7,626 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | ||
| ALX Oncology Holdings Inc | Common | 00166B105 | 71,319 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | ||
| Amyris, Inc | Common | 03236M200 | 50,760 | 11,642,195 | SH | SOLE | 11,642,195 | 0 | 0 | ||
| Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 6,320 | 137,411 | SH | SOLE | 137,411 | 0 | 0 | ||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 51,932 | 442,502 | SH | SOLE | 442,502 | 0 | 0 | ||
| Aslan Pharmaceuticals Ltd | ADS | 04522R101 | 2,556 | 2,840,909 | SH | SOLE | 2,840,909 | 0 | 0 | ||
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | 20,060 | 2,937,093 | SH | SOLE | 2,937,093 | 0 | 0 | ||
| Bellus Health Inc | Common | 07987C204 | 6,998 | 1,017,152 | SH | SOLE | 1,017,152 | 0 | 0 | ||
| Bolt Therapeutics Inc | Common | 097702104 | 10,607 | 3,871,291 | SH | SOLE | 3,871,291 | 0 | 0 | ||
| Celldex Therapeutics Inc | Common | 15117B202 | 21,402 | 628,356 | SH | SOLE | 628,356 | 0 | 0 | ||
| Chinook Therapeutics Inc | Common | 16961L106 | 14,268 | 872,151 | SH | SOLE | 872,151 | 0 | 0 | ||
| Codexis, Inc | Common | 192005106 | 8,004 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | ||
| Cogent Biosciences Inc | Common | 19240Q201 | 14,388 | 1,920,941 | SH | SOLE | 1,920,941 | 0 | 0 | ||
| Compass Therapeutics Inc | Common | 20454B104 | 2,740 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| Design Therapeutics | Common | 25056L103 | 7,697 | 476,589 | SH | SOLE | 476,589 | 0 | 0 | ||
| Dice Therapeutics Inc | Common | 23345J104 | 3,121 | 163,136 | SH | SOLE | 163,136 | 0 | 0 | ||
| Dyne Therapeutics Inc | Common | 26818M108 | 5,568 | 577,642 | SH | SOLE | 577,642 | 0 | 0 | ||
| Eiger BioPharmaceuticals Inc | Common | 28249U105 | 35 | 4,166 | SH | SOLE | 4,166 | 0 | 0 | ||
| Elevation Oncology Inc | Common | 28623U101 | 1,252 | 496,844 | SH | SOLE | 496,844 | 0 | 0 | ||
| Genetron Holdings Ltd | ADS | 37186H100 | 16,231 | 7,411,577 | SH | SOLE | 7,411,577 | 0 | 0 | ||
| Geron Corp | Common | 374163103 | 20,724 | 15,238,095 | SH | SOLE | 15,238,095 | 0 | 0 | ||
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | 2,240 | 961,359 | SH | SOLE | 961,359 | 0 | 0 | ||
| Harmony Biosciences Holdings Inc | Common | 413197104 | 222,338 | 4,570,148 | SH | SOLE | 4,570,148 | 0 | 0 | ||
| Homology Medicines, Inc. | Common | 438083107 | 2,594 | 853,143 | SH | SOLE | 853,143 | 0 | 0 | ||
| Impel NeuroPharma Inc | Common | 45258K109 | 18,376 | 2,884,789 | SH | SOLE | 2,884,789 | 0 | 0 | ||
| Instil Bio Inc | Common | 45783C101 | 134,233 | 12,486,787 | SH | SOLE | 12,486,787 | 0 | 0 | ||
| IO Biotech Inc | Common | 449778109 | 15,982 | 3,015,545 | SH | SOLE | 3,015,545 | 0 | 0 | ||
| Iovance Biotherapeutics Inc | Common | 462260100 | 10,907 | 655,057 | SH | SOLE | 655,057 | 0 | 0 | ||
| Iveric Bio Inc | Common | 46583P102 | 108,250 | 6,431,940 | SH | SOLE | 6,431,940 | 0 | 0 | ||
| KalVista Pharmaceuticals Inc. | Common | 483497103 | 22,605 | 1,533,559 | SH | SOLE | 1,533,559 | 0 | 0 | ||
| Legend Biotech Corp Sponsored | SPONSORED ADS | 52490G102 | 8,881 | 244,375 | SH | SOLE | 244,375 | 0 | 0 | ||
| Mereo Biopharma Group PLC | ADS | 589492107 | 4,251 | 3,795,225 | SH | SOLE | 3,795,225 | 0 | 0 | ||
| Merus NV | Common | N5749R100 | 11,686 | 442,000 | SH | SOLE | 442,000 | 0 | 0 | ||
| Metacrine Inc | Common | 59101E103 | 89 | 146,426 | SH | SOLE | 146,426 | 0 | 0 | ||
| Minerva Surgical Inc | Common | 60343F106 | 9,971 | 2,215,667 | SH | SOLE | 2,215,667 | 0 | 0 | ||
| New Frontier Health Corp | Ord Shs | G6461G106 | 170,885 | 14,300,000 | SH | SOLE | 14,300,000 | 0 | 0 | ||
| Nkarta Inc | Common | 65487U108 | 5,829 | 512,225 | SH | SOLE | 512,225 | 0 | 0 | ||
| Olema Pharmaceuticals Inc | Common | 68062P106 | 7,197 | 1,689,515 | SH | SOLE | 1,689,515 | 0 | 0 | ||
| Precision Biosciences Inc | Common | 74019P108 | 432 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | ||
| Relmada Therapeutics Inc | Common | 75955J402 | 19,052 | 705,882 | SH | SOLE | 705,882 | 0 | 0 | ||
| Satsuma Pharmaceuticals Inc | Common | 80405P107 | 4,683 | 1,232,394 | SH | SOLE | 1,232,394 | 0 | 0 | ||
| Sera Prognostics Inc | Common | 81749D107 | 7,034 | 1,856,011 | SH | SOLE | 1,856,011 | 0 | 0 | ||
| Sierra Oncology, Inc | Common | 82640U404 | 106,711 | 3,329,511 | SH | SOLE | 3,329,511 | 0 | 0 | ||
| Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | ||
| Tarsus Pharmaceuticals Inc | Common | 87650L103 | 50,247 | 2,987,331 | SH | SOLE | 2,987,331 | 0 | 0 | ||
| Terns Pharmaceuticals Inc | Common | 880881107 | 7,945 | 2,675,133 | SH | SOLE | 2,675,133 | 0 | 0 | ||
| Ventyx Biosciences Inc | Common | 92332V107 | 26,078 | 1,921,726 | SH | SOLE | 1,921,726 | 0 | 0 | ||
| Vera Therapeutics Inc | Common | 92337R101 | 15,660 | 666,666 | SH | SOLE | 666,666 | 0 | 0 | ||
| Verona Pharma PLC | ADS | 925050106 | 13,722 | 2,749,918 | SH | SOLE | 2,749,918 | 0 | 0 | ||
| Viridian Therapeutics Inc | Common | 92790C104 | 24,037 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
| Zai Lab Ltd ADR | ADR | 98887Q104 | 7,986 | 181,577 | SH | SOLE | 181,577 | 0 | 0 | ||
| Zymeworks Inc | Common | 98985W102 | 1,874 | 286,064 | SH | SOLE | 286,064 | 0 | 0 | ||